Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors during the central nervous system, conolidine modulates alternate molecular targets. A Science Innovations review found that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide https://conolidine-for-knee-pain67890.jaiblogs.com/65789207/conolidin-to-replace-traditional-painkillers-fundamentals-explained